Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
98.62
-2.05 (-2.04%)
May 22, 2026, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.01 billion as of May 22, 2026. Its market cap has increased by 168.37% in one year.
Market Cap
6.01B
Enterprise Value
5.95B
1-Year Change
168.37%
Ranking
Category
Stock Price
$98.62
Market Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.01B, an increase of 1,923.36%. That is a compound annual growth rate of 55.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 6.01B | 47.31% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kymera Therapeutics | 6.49B |
| Corcept Therapeutics | 6.46B |
| Spyre Therapeutics | 6.43B |
| Protagonist Therapeutics | 6.38B |
| Centessa Pharmaceuticals | 6.15B |
| Apogee Therapeutics | 6.07B |
| Rhythm Pharmaceuticals | 6.02B |
| Scholar Rock Holding | 5.77B |